ARIAD Pharmaceuticals, Inc.

Chinese biotech Ascentage Pharma Group Corporation may license to Takeda Pharmaceutical Co. Ltd. exclusive global rights to a potential successor to the Japanese major’s leukemia drug Iclusig (pon

Covis Pharma is trying to use the US Food and Drug Administration’s words, actions and inactions on accelerated approval against the Center for Drug Evaluation and Research in the company’s bid to ke

Covis Pharma cannot rely on real-world evidence alone to confirm the clinical benefit of the preterm birth prevention drug Makena (hydroxyprogesterone caproate), the US FDA’s Center for Drug Evaluati

If you are looking to invest in or create a healthcare “unicorn”, then ex- Novartis AG chief financial officer George Bickerstaff has some tips to offer on where you could start digging and some of t